Evidence map›Paper›PMID 34640352›Full record

ArticleJournal of clinical medicine2021

Thyroidectomy for Cancer: The Surgeon and the Parathyroid Glands Sparing.

Giuliano Perigli, Fabio Cianchi, Francesco Giudici, Edda Russo, Giulia Fiorenza, Luisa Petrone, Clotilde Sparano, Fabio Staderini, Benedetta Badii, Alessio Morandi

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Giuliano PerigliDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
Fabio CianchiDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.ORCID 0000-0002-6936-8693
Francesco GiudiciDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.ORCID 0000-0002-6879-5685
Edda RussoDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.ORCID 0000-0003-3141-1091
Giulia FiorenzaDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
Luisa PetroneDepartment of Biomedical, Experimental and Clinical Sciences Mario Serio, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
Clotilde SparanoDepartment of Biomedical, Experimental and Clinical Sciences Mario Serio, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
Fabio StaderiniDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.ORCID 0000-0002-2438-2563
Benedetta BadiiDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
Alessio MorandiDepartment of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 6, 50135 Florence, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe diagnosis of thyroid cancer is continuously increasing and consequently the amount of thyroidectomy. Notwithstanding the actual surgical skill, postoperative hypoparathyroidism still represents its most frequent complication. The aims of the present study are to analyze the rate of postoperative hypoparathyroidism after thyroidectomy, performed for cancer by a single first operator, without any technological aid, and to compare the data to those obtained adopting the most recent technological adjuncts developed to reduce the postoperative hypoparathyroidism.

methodsDuring the period 1997-2020 at the Endocrine Surgery Unit of the Department of Clinical and Experimental Medicine of the University of Florence, 1648 consecutive extracapsular thyroidectomies for cancer (401 with central compartment node dissection) were performed. The percentage of hypoparathyroidism, temporary or permanent, was recorded both in the first period (Group A) and in the second, most recent period (Group B). Total thyroidectomies were compared either with those with central compartment dissection and lobectomies. Minimally invasive procedures (MIT, MIVAT, some transoral) were also compared with conventional. Fisher's exact and Chi-square tests were used for comparison of categorical variables.

resultsOn the 1648 thyroidectomies enrolled for the study, the histotype was differentiated in 93.93 % of cases, medullary in 4% and poorly differentiated in the remaining 2.06%. Total extracapsular thyroidectomy and lobectomy were performed respectively in 95.45% and 4.55%. We recorded a total of 318 (19.29%) cases of hypocalcemia, with permanent hypoparathyroidism in 11 (0.66%). In regard to the literature, four categories of tools to facilitate the identification of the parathyroids were identified: (a) vital dye; (b) optical devices; (c) autofluorescence of parathyroids; and (d) autofluorescence enhanced by contrast media. Postoperative hypoparathyroidism had a variable range in the different groups.

conclusionsOur data confirm that the incidence of post-surgical hypoparathyroidism is extremely low in the high volume centers. Its potential reduction adopting technological adjuncts is difficult to estimate, and their cost, together with complexity of application, do not allow immediate routine use. The trend towards increasingly unilateral surgery in thyroid carcinoma, as confirmed by our results in case of lobectomy, is expected to really contribute to a further reduction of postsurgical hypoparathyroidism.

Indexed as

autofluorescencehypocalcemiahypoparathyrodismindocyanine greenmethylene bleuoptical devicesparathyroid glandspostoperative complicationsthyroid carcinoma

Identifiers

PMID34640352
PMCPMC8509338
OpenAlexW3200927521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.